BETHESDA, MD – The Biophysical Society is pleased to announce that Nuria Assa-Munt, of the Center for Scientific Review, National Institutes of Health (retired), USA has been named the recipient of the Society’s 2026 Rosalba Kampman Distinguished Service Award. Assa-Munt will be honored at the Society’s 70th Annual Meeting, being held in San Francisco, California from February 21-25, 2026.

BETHESDA, MD – The Biophysical Society is pleased to announce that Jie Xiao, of the Johns Hopkins School of Medicine, USA, will receive the 2026 Carolyn Cohen Innovation Award. Xiao will be honored at the Society’s 70th Annual Meeting, being held in San Francisco, California from February 21-25, 2026.

BETHESDA, MD – The Biophysical Society is pleased to announce that Wonhwa Cho, of the University of Illinois Chicago, USA, has been named the recipient of the 2026 BPS Award in the Biophysics of Health and Disease. Cho will be honored at the Society’s 70th Annual Meeting, being held in San Francisco, California from February 21-25, 2026.

Researchers from USC and Duke report that the persistent “know-do gap” — where clinicians know guidelines but practice differently — is the primary driver of antibiotic overprescribing for pediatric diarrhea in India’s private sector, not lack of knowledge, point-of-sale profits, or stockouts of clinically recommended treatments such as oral rehydration salts (ORS).

This qualitative study conducted by the American College of Lifestyle Medicine (ACLM) found that intentional educational strategies are critical to the adoption and growth of lifestyle medicine programming and facilitate deepening of clinicians’ knowledge, skills, and confidence in delivering lifestyle medicine interventions to treat, reverse and prevent chronic disease.

Backed by the combined expertise of three USC schools, scientists are developing a new drug aimed at a previously unexplored biological target in Alzheimer’s disease, aided by an $8 million grant from the National Institutes of Health. The team, led by Hussein Yassine of the Keck School of Medicine of USC, is investigating why some carriers of the APOE4 gene — the strongest genetic risk factor for Alzheimer’s — develop dementia while others remain cognitively healthy. His lab has identified an enzyme that predisposes the brain to inflammation and the research team is now working to find a drug that can block it without harmful side effects. Their work points to an enzyme which breaks down protective omega-3 fatty acids in the brain and triggers damaging inflammation.